Sambade, Maria J.
Prince, Grace
Deal, Allison M.
Trembath, Dimitri
McKee, Megan
Garrett, Amy
Keith, Kevin
Ramirez, Juanita
Midkiff, Bentley
Blackwell, Kimberly
Sammons, Sarah
Leone, Jose Pablo
Brufsky, Adam
Morikawa, Aki
Brogi, Edi
Seidman, Andrew
Ewend, Matthew
Carey, Lisa A.
Moschos, Stergios J.
Hamilton, Ronald L.
Vincent, Benjamin
Anders, Carey http://orcid.org/0000-0001-9165-4074
Funding for this research was provided by:
NIH/NCI (5-K23-CA157728-05)
Article History
Received: 31 December 2018
Accepted: 19 March 2019
First Online: 23 April 2019
Compliance with ethical standards
:
: Adam Brufksy is a consultant for Lilly, Amgen, Hexal, Novartis, Roche, Pfizer, Immunomedics, Eisai, and Celgene, and owns stock in Bioarray Technologies. Kimberly Blackwell is employed by Lilly. Jose Pablo Leone receives research funding from Merck. Aki Morikawa receives research funding from Lilly, Genentech, Novartis, Merrimack, and Bayer. Matthew Ewend owns stock in Falcon Therapeutics. Carey Anders is an uncompensated consultant/advisory board member for Novartis, Merrimack, Lily, Nektar, Cascadian, Seattle Genetics, and Genentech, a compensated consultant/advisory board member for Merck, PUMA, and Eisai, receives unrelated research funding from Novartis, Merrimack, PUMA, Lily, Merck, Cascadian, Seattle Genetics, Nektar, Tesaro, and G1-Therapeutics, and receives honoraria from UptoDate and Jones and Bartlett Publishing. The other authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: This article does not contain any studies with animals performed by any of the authors.
: Informed consent or waiver of consent granted by local IRB was obtained from all individual participants included in the study.